Publications by authors named "K D Finkelstein"

Claim this Profile
C
Corrigendum to "OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer" [Gynecol Oncol 2025 Jun 197 182-191].
Premal H Thaker, Debra L Richardson, Andrea R Hagemann, Robert W Holloway, Mark Reed, Karen Finkelstein

Gynecol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer.
Premal H Thaker, Debra L Richardson, Andrea R Hagemann, Robert W Holloway, Mark Reed, Karen Finkelstein

Gynecol Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label randomized active-controlled phase II clinical study to assess the efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer (PROFECTA-II/GOG-3044).
Thomas J Herzog, John B Liao, Karen Finkelstein, Lyndsay Willmott, Wei Duan

Gynecol Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated Neuropsychological Assessment Metrics: Normative Reference Values for U. S. Army National Guard Soldiers.
Kristin J Heaton, Ashley A Donovan, Caitlin Haven, Katherine Finkelstein, Nicole Ekon

Arch Clin Neuropsychol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study.
Brian M Slomovitz, Virginia L Filiaci, Joan L Walker, Michael C Taub, Karen A Finkelstein

Gynecol Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis